Transmedics Group Inc

NASDAQ:TMDX   3:59:50 PM EDT
26.88
-0.15 (-0.56%)
Products

Transmedics Receives FDA Approval For Its OCS Liver System For Preservation And Assessment Of Donor Livers For Transplantation

Published: 09/29/2021 11:25 GMT
Transmedics Group Inc (TMDX) - Transmedics Receives FDA Approval for Its Ocs Liver System for Preservation and Assessment of Donor Livers for Transplantation.
Transmedics Group Inc - Expects to Expand Commercial Activities With All Three Ocs Systems Starting in Q4 of 2021.